(Q28656379)

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The Spread of Obesity in a Large Social Network over 32 Years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The genetics of human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Nutrient sensing and inflammation in metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Adenovirus 36 infection and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Microbial ecology: human gut microbes associated with obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Early differences in fecal microbiota composition in children may predict overweight.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Human colonic microbiota associated with diet, obesity and weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Human gut microbiota in obesity and after gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

A core gut microbiome in obese and lean twins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Interplay between weight loss and gut microbiota composition in overweight adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Microbiota and SCFA in lean and overweight healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Gut bacteria alteration in obese people and its relationship with gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The gut microbiota as an environmental factor that regulates fat storage

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Obesity alters gut microbial ecology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Gut microbiomes of Malawian twin pairs discordant for kwashiorkor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Publication biases in probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Why the European Food Safety Authority was right to reject health claims for probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Relationship between funding source and conclusion among nutrition-related scientific articles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Industry funding and the reporting quality of large long-term weight loss trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Effect of feeding diets containing an antibiotic, a probiotic, or yucca extract on growth and intestinal urease activity in broiler chicks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Growth performance and immune response of two commercial broiler strains fed diets containing Lactobacillus cultures and oxytetracycline under heat stress conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Evaluation of the efficacy of a probiotic containing Lactobacillus, Bifidobacterium, Enterococcus, and Pediococcus strains in promoting broiler performance and modulating cecal microflora composition and metabolic activities.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antiobesity effect of trans-10,cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antibiotic administration alters the community structure of the gastrointestinal micobiota.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antibiotics in early life alter the murine colonic microbiome and adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

In-feed antibiotic effects on the swine intestinal microbiome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Human microbiome: take-home lesson on growth promoters?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Vancomycin treatment of infective endocarditis is linked with recently acquired obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Why and how antibiotics are used in swine production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The European ban on growth-promoting antibiotics and emerging consequences for human and animal health

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Chromatographic analysis of banned antibacterial growth promoters in animal feed

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Functional genomics of probiotic Lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Diversity of the genus Lactobacillus revealed by comparative genomics of five species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Comparative genomics of Bifidobacterium, Lactobacillus and related probiotic genera

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Rapid and accurate bacterial identification in probiotics and yoghurts by MALDI-TOF mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics as a help in children suffering from malnutrition and diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

How many child deaths can we prevent this year?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Recent advancements in drug treatment of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antibiotics as part of the management of severe acute malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Macrolide antibiotics for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Gut microbiota: Adding weight to the microbiota's role in obesity--exposure to antibiotics early in life can lead to increased adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Infant antibiotic exposures and early-life body mass

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Growth and development of Central American children. I. Growth responses of rural Guatemalan school children to daily administration of penicillin and aureomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Bacteriocins - a viable alternative to antibiotics?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Metagenomics and probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast-milk and the infant gut

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Human milk is a source of lactic acid bacteria for the infant gut

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Faecal microbiota in breast-fed infants after antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

New antibiotic structures from fermentations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The expansion of mechanistic and organismic diversity associated with non-ribosomal peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The historical delivery of antibiotics from microbial natural products--can history repeat?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

New antibiotics from bacterial natural products

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Molecular engineering approaches to peptide, polyketide and other antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

StreptomeDB: a resource for natural compounds isolated from Streptomyces species

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Microbial shifts in the swine distal gut in response to the treatment with antimicrobial growth promoter, tylosin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Bacteriocin production: a probiotic trait?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Bacteriocins: developing innate immunity for food

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Impact of lactobacilli on orally acquired listeriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Molecular characterization of antimicrobial compound produced by Lactobacillus acidophilus AA11.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Occam's razor and probiotics activity on Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Meta-analysis of probiotics for the prevention of traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics for prevention and treatment of diarrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Bioengineered microbes in disease therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics and digestive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics for the treatment of eczema: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

The relationship between gut microbiota and weight gain in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

Gut metagenome in European women with normal, impaired and diabetic glucose control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2813%2970179-8

7 January 2021

10.1016/S1473-3099(13)70179-8

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24070562

1 reference

Consolidated OpenCitations Corpus – April 2017